185 related articles for article (PubMed ID: 12609839)
1. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Wu KD; Orme LM; Shaughnessy J; Jacobson J; Barlogie B; Moore MA
Blood; 2003 Jun; 101(12):4982-9. PubMed ID: 12609839
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Wang Y; Fang M; Sun X; Sun J
Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
Aref S; Goda T; El-Sherbiny M
Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
[TBL] [Abstract][Full Text] [Related]
6. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
[TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
Rigolin GM; Tieghi A; Ciccone M; Bragotti LZ; Cavazzini F; Della Porta M; Castagnari B; Carroccia R; Guerra G; Cuneo A; Castoldi G
Br J Haematol; 2003 Mar; 120(6):953-9. PubMed ID: 12648064
[TBL] [Abstract][Full Text] [Related]
8. Telomere shortening in patients with plasma cell disorders.
Cottliar A; Pedrazzini E; Corrado C; Engelberger MI; Narbaitz M; Slavutsky I
Eur J Haematol; 2003 Nov; 71(5):334-40. PubMed ID: 14667196
[TBL] [Abstract][Full Text] [Related]
9. The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.
Chan D; Martin-Ruiz C; Saretzki G; Neely D; Qiu W; Kunadian V
PLoS One; 2020; 15(1):e0227616. PubMed ID: 31923255
[TBL] [Abstract][Full Text] [Related]
10. Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS.
Li Y; Deng B; Ouyang N; Yuan P; Zheng L; Wang W
J Assist Reprod Genet; 2017 Jul; 34(7):849-859. PubMed ID: 28477298
[TBL] [Abstract][Full Text] [Related]
11. [Telomerase activity, mTert gene expression and the telomere length in mouse mesenchymal stem cells in the late period after γ- and γ,n-irradiation and in the tumors developed from these cells].
Vysotskaya OV; Glukhov AI; Semochkina YP; Gordeev SA; Moskaleva EY
Biomed Khim; 2020 May; 66(3):265-273. PubMed ID: 32588833
[TBL] [Abstract][Full Text] [Related]
12. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
[TBL] [Abstract][Full Text] [Related]
13. Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial.
Innes KE; Selfe TK; Brundage K; Montgomery C; Wen S; Kandati S; Bowles H; Khalsa DS; Huysmans Z
J Alzheimers Dis; 2018; 66(3):947-970. PubMed ID: 30320574
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
15. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity.
Spyridopoulos I; Hoffmann J; Aicher A; Brümmendorf TH; Doerr HW; Zeiher AM; Dimmeler S
Circulation; 2009 Oct; 120(14):1364-72. PubMed ID: 19770396
[TBL] [Abstract][Full Text] [Related]
16. Targeting Telomere Biology in Acute Lymphoblastic Leukemia.
Karow A; Haubitz M; Oppliger Leibundgut E; Helsen I; Preising N; Steiner D; Dantonello TM; Ammann RA; Roessler J; Kartal-Kaess M; Röth A; Baerlocher GM
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206297
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro.
Dratwa M; Wysoczanska B; Turlej E; Anisiewicz A; Maciejewska M; Wietrzyk J; Bogunia-Kubik K
Exp Cell Res; 2020 Nov; 396(1):112298. PubMed ID: 32971118
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Initial Telomere Length, Initial Telomerase Activity, Age, and Replicative Capacity of Nucleus Pulposus Chondrocytes in Human Intervertebral Discs: What Is a Predictor of Replicative Potential?
Lee JS; Jeong SW; Cho SW; Juhn JP; Kim KW
PLoS One; 2015; 10(12):e0144177. PubMed ID: 26633809
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohort.
Dowd JB; Bosch JA; Steptoe A; Blackburn EH; Lin J; Rees-Clayton E; Aiello AE
Exp Gerontol; 2013 Apr; 48(4):385-90. PubMed ID: 23403382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
